These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29747683)

  • 1. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
    Thordardottir S; Rodriguez-Vieitez E; Almkvist O; Ferreira D; Saint-Aubert L; Kinhult-Ståhlbom A; Thonberg H; Schöll M; Westman E; Wall A; Eriksdotter M; Zetterberg H; Blennow K; Nordberg A; Graff C
    Alzheimers Res Ther; 2018 May; 10(1):45. PubMed ID: 29747683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in PSEN1 (p.T119I) in an Argentine family with early- and late-onset Alzheimer's disease.
    Itzcovich T; Chrem-Méndez P; Vázquez S; Barbieri-Kennedy M; Niikado M; Martinetto H; Allegri R; Sevlever G; Surace EI
    Neurobiol Aging; 2020 Jan; 85():155.e9-155.e12. PubMed ID: 31153663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
    Schöll M; Wall A; Thordardottir S; Ferreira D; Bogdanovic N; Långström B; Almkvist O; Graff C; Nordberg A
    Neurology; 2012 Jul; 79(3):229-36. PubMed ID: 22700814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
    Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
    Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
    Knight WD; Okello AA; Ryan NS; Turkheimer FE; Rodríguez Martinez de Llano S; Edison P; Douglas J; Fox NC; Brooks DJ; Rossor MN
    Brain; 2011 Jan; 134(Pt 1):293-300. PubMed ID: 21084313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.
    Ringman JM; Gylys KH; Medina LD; Fox M; Kepe V; Flores DL; Apostolova LG; Barrio JR; Small G; Silverman DH; Siu E; Cederbaum S; Hecimovic S; Malnar M; Chakraverty S; Goate AM; Bird TD; Leverenz JB
    Neurosci Lett; 2011 Jan; 487(3):287-92. PubMed ID: 21094210
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Quiroz YT; Aguillon D; Aguirre-Acevedo DC; Vasquez D; Zuluaga Y; Baena AY; Madrigal L; Hincapié L; Sanchez JS; Langella S; Posada-Duque R; Littau JL; Villalba-Moreno ND; Vila-Castelar C; Ramirez Gomez L; Garcia G; Kaplan E; Rassi Vargas S; Ossa JA; Valderrama-Carmona P; Perez-Corredor P; Krasemann S; Glatzel M; Kosik KS; Johnson K; Sperling RA; Reiman EM; Sepulveda-Falla D; Lopera F; Arboleda-Velasquez JF
    N Engl J Med; 2024 Jun; 390(23):2156-2164. PubMed ID: 38899694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
    J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
    Natelson Love M; Clark DG; Cochran JN; Den Beste KA; Geldmacher DS; Benzinger TL; Gordon BA; Morris JC; Bateman RJ; Roberson ED
    Neurobiol Aging; 2017 Jan; 49():216.e7-216.e13. PubMed ID: 27793474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    Sánchez-Valle R; Monté GC; Sala-Llonch R; Bosch B; Fortea J; Lladó A; Antonell A; Balasa M; Bargalló N; Molinuevo JL
    J Alzheimers Dis; 2016; 51(3):827-35. PubMed ID: 26923015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia.
    Testi S; Peluso S; Fabrizi GM; Antenora A; Russo CV; Pappatà S; Padovani A; Ferrarini M; Filla A
    J Alzheimers Dis; 2014; 41(3):709-14. PubMed ID: 24718101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin-1 mutation is associated with a hippocampus defect in alzheimer's disease: Meta-Analysis for neuroimaging research.
    Gu X; Zhao M; Han X; Liu L
    Clin Neurol Neurosurg; 2020 Apr; 191():105679. PubMed ID: 32004985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.